More Than 9,000 Taxotere Cases Over Long-Term Hair Loss Pending in MDL
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
«
»
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
A series of five bellwether trials for Taxotere hairloss lawsuits have been scheduled to begin in 2019.…
Four Taxotere hair loss claims have been selected as candidates for the first bellwether trial slated to begin in September.…
Lawsuits have been filed on behalf of more than 7,500 women who suffered permanent hair loss from Taxotere, claiming that the manufacturer failed to adequately warn about the risks associated with the breast cancer drug, which is not seen with other, equally effective treatment options.…
Defendants have asked the federal judge overseeing all Plavix lawsuits to dismiss those claims, saying the lawsuits are preempted by federal law.…
A federal judge has called for parties to select eight Taxotere hair loss lawsuits which could serve as the second Taxotere bellwether trial, scheduled for January 2019.…
A recent court order requires that all Taxotere claims being pursued by women left with permanent hair loss following breast cancer treatments must be reported to be eligible for participation in any potential settlement program that may resolve the litigation.…
Parties involved in Taxotere hair loss litigation will meet for a settlement conference in June of next year ahead of the first bellwether trials, in order to see if a settlement agreement can be reached.…
A Taxotere class action lawsuit has been denied certification by a federal judge, who says there are too many individual aspects of the claims to merit class status.…
Sanofi-Aventis is opposing certification of a Taxotere class action lawsuit seeking to represent all women in Louisiana who suffered long-term or permanent hair loss after using the chemotherapy drug.…